Possibilities for MS Management

Multiple sclerosis (MS) is one of the many chronic conditions that MSCs have shown some promise in helping.

Stem cell advocate and Celltex client SammyJo Wilkinson has fought long and hard to see progress in any area of research that shows a potential for stopping, slowing, or recovering from the progressive disease she has lived most of her life with.

In this webinar, we discuss how one’s own adipose-derived Mesenchymal Stem Cells (MSCs) can help to counter the expected decline caused by MS with a look into retrospective studies on Celltex clients with MS who have used their own stem cells.

SammyJo shares her journey with progressive MS, what results she has seen in using her stem cells, and her advocacy efforts.

Dr. Stanley Jones, Celltex's Chief Medical Officer, also joins the discussion to provide a medical perspective on the properties of MSCs that are particularly promising for alleviating the symptoms of MS.

Click above to register for this webinar.

ABOUT THE GUESTS:

SammyJo Wilkinson

Celltex Client, Multiple Sclerosis

SammyJo Wilkinson was diagnosed with Multiple Sclerosis (MS) in 1995 at the age of 30. Having tried traditional medications for nearly 20 years, her MS progressed to a point where she was bound to a wheelchair and searching for nursing homes because her mobility had become so limited.

Looking for other options, SammyJo found Celltex in 2012 and began using her own MSCs. Following this first round of therapy, she noticed immediate improvements. She had regained feeling in her hands and experienced higher energy levels. Improvements kept coming following more rounds of therapy. She reached a point where she could walk using a walker, something that hadn't been possible since she became wheelchair-bound.

SammyJo now spends much of her time advocating for the increased accessibility of one's own MSCs for therapeutic applications. She has spoken at a FDA hearing and even started her own organization, Patients for Stem Cells, to fight for this cause.

Stanley C. Jones, MD

Chief Medical Officer, Celltex Therapeutics

Dr. Stanley Jones serves as the Celltex Chief Medical Officer and a board-certified orthopedic spine surgeon. After suffering from a sudden onset of psoriatic arthritis, which prevented him from performing surgeries at full capacity, Jones traveled to South Korea to receive the treatment of his own stem cells. This treatment allowed him to return to a normal surgery schedule and enjoy life pain-free. Dr. Jones was soon motivated to help bring stem cell technology to the state of Texas, so that more individuals could experience the quality of life improvements that he saw. Through these efforts, he has gained extensive knowledge on the clinical applications of stem cells.

Dr. Jones is an orthopedic spine surgeon who has an active spine practice in the state of Texas and is a board-certified member of the American Board of Orthopedic Surgery.

Dr. Jones received a B.A. in chemistry from Texas Tech University and an M.D. from the University of Texas Southwestern Medical School. He completed an internship at the University of Utah and an orthopedic residency at the University of Texas Medical School in Houston. He then served in the U.S. Army as a Captain in the Medical Corps.

Register Now